Jun 30, 2021

Encompass Health Q2 2021 Earnings Report

Encompass Health reported strong revenue and earnings growth in both segments due to accelerated business momentum.

Key Takeaways

Encompass Health Corporation reported strong second-quarter results, with significant revenue and earnings growth in both segments. The company is raising its full-year 2021 guidance as a result of strong operating trends and year-to-date performance.

Net operating revenues increased by 19.9% compared to Q2 2020.

Income from continuing operations attributable to Encompass Health per diluted share increased by 232.4% compared to Q2 2020.

Adjusted earnings per share increased by 277.4% compared to Q2 2020.

Adjusted EBITDA increased by 71.9% compared to Q2 2020.

Total Revenue
$1.29B
Previous year: $1.07B
+19.9%
EPS
$1.17
Previous year: $0.31
+277.4%
Net patient revenue per discharge
$19.7K
Previous year: $19.4K
+1.8%
Discharges
49.49K
Previous year: 41.68K
+18.7%
Gross Profit
$1.24B
Previous year: $1.02B
+20.9%
Cash and Equivalents
$73.2M
Previous year: $419M
-82.5%
Free Cash Flow
$142M
Previous year: $168M
-15.6%
Total Assets
$6.61B
Previous year: $6.5B
+1.7%

Encompass Health

Encompass Health

Encompass Health Revenue by Segment

Forward Guidance

The Company increased its full-year guidance to reflect its second quarter results and strong operating trends.

Positive Outlook

  • Net operating revenues updated guidance: $5,100 to $5,250 million
  • Adjusted EBITDA updated guidance: $1,050 to $1,070 million
  • Adjusted earnings per share from continuing operations attributable to Encompass Health updated guidance: $4.32 to $4.47

Revenue & Expenses

Visualization of income flow from segment revenue to net income